1. Home
  2. EDSA vs SONM Comparison

EDSA vs SONM Comparison

Compare EDSA & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • SONM
  • Stock Information
  • Founded
  • EDSA 2015
  • SONM 1999
  • Country
  • EDSA Canada
  • SONM United States
  • Employees
  • EDSA N/A
  • SONM N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • SONM Telecommunications Equipment
  • Sector
  • EDSA Health Care
  • SONM Telecommunications
  • Exchange
  • EDSA Nasdaq
  • SONM Nasdaq
  • Market Cap
  • EDSA 13.8M
  • SONM 12.6M
  • IPO Year
  • EDSA N/A
  • SONM 2019
  • Fundamental
  • Price
  • EDSA $2.10
  • SONM $0.74
  • Analyst Decision
  • EDSA Strong Buy
  • SONM
  • Analyst Count
  • EDSA 2
  • SONM 0
  • Target Price
  • EDSA $13.00
  • SONM N/A
  • AVG Volume (30 Days)
  • EDSA 13.1K
  • SONM 12.4M
  • Earning Date
  • EDSA 08-08-2025
  • SONM 08-08-2025
  • Dividend Yield
  • EDSA N/A
  • SONM N/A
  • EPS Growth
  • EDSA N/A
  • SONM N/A
  • EPS
  • EDSA N/A
  • SONM N/A
  • Revenue
  • EDSA N/A
  • SONM $58,243,000.00
  • Revenue This Year
  • EDSA N/A
  • SONM $127.68
  • Revenue Next Year
  • EDSA N/A
  • SONM N/A
  • P/E Ratio
  • EDSA N/A
  • SONM N/A
  • Revenue Growth
  • EDSA N/A
  • SONM N/A
  • 52 Week Low
  • EDSA $1.55
  • SONM $0.60
  • 52 Week High
  • EDSA $5.59
  • SONM $6.38
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 60.43
  • SONM 40.13
  • Support Level
  • EDSA $2.05
  • SONM $0.60
  • Resistance Level
  • EDSA $2.17
  • SONM $0.74
  • Average True Range (ATR)
  • EDSA 0.09
  • SONM 0.21
  • MACD
  • EDSA 0.02
  • SONM -0.05
  • Stochastic Oscillator
  • EDSA 96.30
  • SONM 6.30

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

Share on Social Networks: